Bluett RJ

References (2)

Title : Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors - Bedse_2018_Transl.Psychiatry_8_92
Author(s) : Bedse G , Bluett RJ , Patrick TA , Romness NK , Gaulden AD , Kingsley PJ , Plath N , Marnett LJ , Patel S
Ref : Transl Psychiatry , 8 :92 , 2018
Abstract : Bedse_2018_Transl.Psychiatry_8_92
ESTHER : Bedse_2018_Transl.Psychiatry_8_92
PubMedSearch : Bedse_2018_Transl.Psychiatry_8_92
PubMedID: 29695817

Title : Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking - Holleran_2016_Neuropsychopharmacology_41_2062
Author(s) : Holleran KM , Wilson HH , Fetterly TL , Bluett RJ , Centanni SW , Gilfarb RA , Rocco LE , Patel S , Winder DG
Ref : Neuropsychopharmacology , 41 :2062 , 2016
Abstract : Holleran_2016_Neuropsychopharmacology_41_2062
ESTHER : Holleran_2016_Neuropsychopharmacology_41_2062
PubMedSearch : Holleran_2016_Neuropsychopharmacology_41_2062
PubMedID: 26751284